NK Cell Therapy for AML
Clinical trial NCT05256277 · TERMINATED
Trial details
- NCT number
- NCT05256277
- Sponsor
- Zhejiang University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2022-08-28
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.